Feb 28 (Reuters) - Anteris Technologies Ltd (AVR) :
- FY LOSS ATTRIBUTABLE A$67.3 MILLION VERSUS LOSS A$44.3 MILLION
- GROUP IS AIMING TO SECURE APPROVAL FROM FDA TO UNDERTAKE A PIVOTAL CLINICAL TRIAL
- FY REVENUE FROM ORDINARY ACTIVITIES A$4.1 MILLION VERSUS A$4.6 MILLION
News: AVR Anteris Technologies Announces FY Loss Attributable Of A$67.3 Mln
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$7.90 |
Change
-0.260(3.19%) |
Mkt cap ! $113.5M | |||
| Open | High | Low | Value | Volume |
| $8.20 | $8.20 | $7.85 | $70.50K | 8.878K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1000 | $7.80 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $8.00 | 1364 | 1 |
View Market Depth
| Last trade - 16.10pm 19/09/2025 (20 minute delay) ? |
| AVR (ASX) Chart |